Seeking Alpha

Dreyfuss

Dreyfuss
Send Message
View as an RSS Feed
Latest  |  Highest rated
  • A Comprehensive Overview Of Active Electroporation Cancer Trials [View article]
    I would like to thank the author for taking on board some of the constructive criticism voiced in readers' comments. Your revised article, beefed up with carefully researched detail and sound analysis, should prove very useful for investors.
    May 19, 2013. 06:07 AM | Likes Like |Link to Comment
  • A Comprehensive Overview Of Active Electroporation Cancer Trials [View article]
    SCANCELL (SCLP.L) was badly researched in this article. The company is due to complete its Phase I/II trial for melanoma in November this year and will then be offering itself for sale. So Scancell's rather than OncoSec's trial will be the closest to completion. Also Scancell will provide the fastest and greatest return for investors as the company has stated that it expects to sell Scancell "at a very attractive multiple of current valuation."

    The details of Scancell's sale are provided in this recent video interview:
    http://bit.ly/17qOSS9
    May 14, 2013. 02:14 PM | 1 Like Like |Link to Comment
COMMENTS STATS
2 Comments
1 Like